Allyx Therapeutics
Developer of a therapeutic drug designed to reverse neurodegeneration. The company's drug is an orally bioavailable small molecule that acts as a silent allosteric modulator of mGluR5, enabling clinic...
Valuation
$0
Share Price
N/A
Total Raised
$9.9M
Last Round
N/A